A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.
New immunotherapy shows long-term benefits in preventing squamous cell carcinoma
- Post author:
- Post published:January 2, 2025
- Post category:uncategorized